Sponsor Pipeline

Genoss Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
13
Active Trials
3
Recruiting
1
Disease Areas
Active Trials by Phase
Not specified
13
Active Trials
NCT IDTitleConditionStatus
Not specified
NCT06066450 Efficacy of OSFIT Drug-Eluting Stent in Coronary Ostial Artery Stenosis Drug-eluting Stent Recruiting
NCT06075420 Efficacy and Safety of Short Duration of DAPT After GENOSS® DES Implantation in Patients… Percutaneous Coronary Intervention Recruiting
NCT06075433 Efficacy and Safety of 1-year Duration of DAPT After GENOSS® DES Implantation in Patients… Coronary Artery Disease Recruiting
NCT07158307 Safety and Efficacy of GENOSS® DCB With a Shellac Plus Vitamin E Excipient in Patients… Coronary Artery Disease(CAD) Enrolling by Invitation
NCT07159087 The Safety and Efficacy for In-segment Late Lumen Loss of the 'Genoss® SCB' Versus… Coronary Arterial Disease (CAD) Enrolling by Invitation
NCT06841510 Efficacy and Safety of GENOSS SES in Patients With Coronary Artery Disease Coronary Arterial Disease (CAD) Active, Not Recruiting
NCT06086496 Effectiveness and Safety of Abluminal Biodegradable Polymer Sirolimus-eluting Stent… Coronary Artery Disease Enrolling by Invitation
NCT06168305 Safety and Effectiveness of GENOSS® DES in Patients With Multivessel Coronary Artery… Percutaneous Coronary Intervention Enrolling by Invitation
NCT06075368 Efficacy and Safety of GENOSS® SES in Patients With Acute Coronary Syndrome (GENOSS ACS) Acute Coronary Syndrome Active, Not Recruiting
NCT07399080 Clinical Outcomes of GENOSS PCB for Femoropopliteal Artery Disease PTA (Percutaneous Transluminal Angioplasty ) Enrolling by Invitation
NCT07425171 Safety and Effectiveness of GENOSS PCB in Patients With Long Femoropopliteal Lesion PTA (Percutaneous Transluminal Angioplasty) Not Yet Recruiting
NCT07431437 One-Year Results of GENOSS PCB Real-World Study in Femoropopliteal Artery Disease PTA (Percutaneous Transluminal Angioplasty) Enrolling by Invitation
NCT07539324 Clinical Impact of DCB-based Versus DES-based Intervention in Patients With MVCAD Multi Vessel Coronary Artery Disease Not Yet Recruiting
Disease Areas
Get alerts when Genoss Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free